Genomics

Dataset Information

0

RNA sequence data in whole cell extracts of differentiated human podocytes


ABSTRACT: Sphingomyelin phosphodiesterase acid-like 3b (SMPDL3b) is a lipid raft enzyme that regulates plasma membrane (PM) fluidity. Here we report that SMPDL3b excess, as observed in podocytes in diabetic kidney disease (DKD), impairs insulin receptor isoform B-dependent pro-survival insulin signaling by interfering with insulin receptor isoforms binding to caveolin-1 in PM. SMPDL3b excess affects the production of active sphingolipids resulting in decreased ceramide-1-phosphate (C1P) content as observed in human podocytes in vitro and in kidney cortexes of diabetic db/db mice in vivo. Podocyte-specific Smpdl3b deficiency in db/db mice is sufficient to restore kidney cortex C1P content and to protect from DKD. Exogenous administration of C1P restores IR signaling in vitro and prevents established DKD progression in vivo. Taken together, we identified SMPDL3b as a modulator of insulin signaling and demonstrated that supplementation with exogenous C1P may represent a lipid therapeutic strategy to treat diabetic complications such as DKD.

ORGANISM(S): Homo sapiens

PROVIDER: GSE129666 | GEO | 2019/04/12

REPOSITORIES: GEO

Similar Datasets

| E-GEOD-46897 | biostudies-arrayexpress
| E-GEOD-46899 | biostudies-arrayexpress
2022-07-08 | GSE141680 | GEO
2013-07-11 | GSE46897 | GEO
2013-07-13 | GSE46899 | GEO
2022-02-15 | GSE196780 | GEO
2020-07-28 | GSE155188 | GEO
2023-04-25 | GSE225477 | GEO
2021-11-05 | GSE181382 | GEO
2023-08-02 | PXD029745 | Pride